$4.75
+0.250 (+5.56%)
At Close: Jun 03, 2026
Veradigm Reveals New Insights on the Prevalence of Cardiovascular Conditions in the U.S.
08:01am, Tuesday, 20'th Feb 2024
CHICAGO--(BUSINESS WIRE)-- #healthIT--Which region of the U.S. has the highest rates of hypertension, coronary artery disease and heart failure? The South, according to this analysis on cardiovascular
Veradigm and American College of Cardiology Launch Influenza Vaccination Education Initiative to Improve Cardiovascular Health
08:01am, Tuesday, 13'th Feb 2024
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the launch of TRANSFORM VAX, an American College of C
Lawsuit Notice: Investors who lost money with Veradigm Inc. (NASDAQ: MDRX) shares should contact the Shareholders Foundation
09:45am, Tuesday, 06'th Feb 2024
SAN DIEGO , Feb. 6, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in Veradigm Inc. (NASDAQ: MDRX) shares. Investors, who purchased sh
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Veradigm Inc.- MDRX
02:38pm, Monday, 22'nd Jan 2024
NEW YORK , Jan. 22, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX). Such investors are adv
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in Veradigm Inc. with Losses to Contact the Firm
07:00am, Monday, 22'nd Jan 2024
LOS ANGELES, CA / ACCESSWIRE / January 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "
NEW YORK , Jan. 21, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. (NAS
Veradigm's (MDRX) Acquires Koha Health to Solidify Market Presence
09:46am, Friday, 05'th Jan 2024
Veradigm's (MDRX) acquisition of Koha Health will likely enhance its ability to deliver efficient revenue cycle services by incorporating Musculoskeletal Medicine specialty subject matter expertise.
Veradigm Leadership Team to Present at J.P. Morgan Healthcare Conference
04:01pm, Thursday, 04'th Jan 2024
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that Dr. Shih-Yin Ho, Veradigm interim Chief Executi
Veradigm's (MDRX) New Offering to Enhance Patient Engagement
01:32pm, Friday, 10'th Nov 2023
Veradigm's (MDRX) latest solution is likely to offer its clients the right payment option to each individual patient through the right communication channel.
Veradigm (MDRX)-FDB Vela to Enhance Pharmacy Connectivity
12:02pm, Monday, 09'th Oct 2023
Veradigm's (MDRX) latest progress with FDB Vela is likely to offer prescribers and patients greater choice and cost transparency.
Veradigm (MDRX) Advances Tie-Up to Enhance Care Delivery
02:16pm, Wednesday, 04'th Oct 2023
Veradigm's (MDRX) new phase of strategic investment is likely to drive innovation and close the evidence gap in behavioral health.
Veradigm's (MDRX) New Tie-Up to Boost Patients' Health Outcomes
11:16am, Friday, 29'th Sep 2023
Veradigm's (MDRX) latest partnership is likely to promote value-based care initiatives for healthcare providers and the patients they serve.
Veradigm: Some Promise Combined With Uncertainty
10:50am, Friday, 22'nd Sep 2023
Veradigm Inc. is a small-cap firm in the healthcare industry and its stock is trading near its 52-week low. The company was birthed out of Allscripts Healthcare Solutions, and the new entity provides
Here's Why You Should Retain Veradigm (MDRX) Stock for Now
01:41pm, Monday, 15'th May 2023
Veradigm (MDRX) continues to hold on to investors' interests owing to its strategic alliances.
3 Service Stocks Poised to Beat Earnings Estimates in Q4
09:47am, Wednesday, 22'nd Feb 2023
Here we pick three business service stocks, namely PagSeguro Digital (PAGS), Veradigm (MDRX) and TuSimple (TSP), which are likely to pull off earnings surprises this time around.
Sign In
Buy MDRX